EGFR and neoplasm: EGFR mutant-specific immune responses were not seen in diseased, non-vaccinated adjuvant control mice, indicating that the mice are tolerant to the transgene product and that prophylactic vaccination with Emut Vax can break this immune tolerance resulting in inhibition of tumor development.